Pages that link to "Q29614210"
Jump to navigation
Jump to search
The following pages link to The Ink4/Arf locus is a barrier for iPS cell reprogramming (Q29614210):
Displaying 50 items.
- Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability (Q21183968) (← links)
- Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research (Q21560780) (← links)
- Primordial germ cells in mice (Q22065789) (← links)
- Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK⁴a regulation (Q24322448) (← links)
- Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner (Q24337323) (← links)
- Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor (Q24337508) (← links)
- Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies (Q24617141) (← links)
- Tumor suppressors: enhancers or suppressors of regeneration? (Q24618747) (← links)
- Regulation of pluripotency and self- renewal of ESCs through epigenetic-threshold modulation and mRNA pruning (Q24619000) (← links)
- Cellular senescence and tumor suppressor gene p16 (Q24629853) (← links)
- Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective (Q24633489) (← links)
- Direct cell reprogramming is a stochastic process amenable to acceleration (Q24644898) (← links)
- Induced neuronal cells: how to make and define a neuron (Q26269839) (← links)
- Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells (Q26740026) (← links)
- Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies (Q26750380) (← links)
- Epigenetic modulators, modifiers and mediators in cancer aetiology and progression (Q26766149) (← links)
- Pluripotent Stem Cells: Current Understanding and Future Directions (Q26769981) (← links)
- Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis (Q26774960) (← links)
- Cell-based therapies of liver diseases: age-related challenges (Q26776328) (← links)
- Concise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem Cells (Q26799570) (← links)
- Energy metabolism plasticity enables stemness programs (Q26822945) (← links)
- Reprogramming of gastrointestinal cancer cells (Q26824284) (← links)
- MYC and the art of microRNA maintenance (Q26825457) (← links)
- Metastatic cancer stem cells: from the concept to therapeutics (Q26850739) (← links)
- Shared mechanisms in stemness and carcinogenesis: lessons from oncogenic viruses (Q26863339) (← links)
- microRNAs as novel regulators of stem cell pluripotency and somatic cell reprogramming (Q26997070) (← links)
- The genomic stability of induced pluripotent stem cells (Q26998764) (← links)
- The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation (Q26999027) (← links)
- Hematopoietic stem cell engineering at a crossroads (Q27001570) (← links)
- The cell cycle and pluripotency (Q27009037) (← links)
- Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality (Q27014026) (← links)
- Direct lineage conversion: induced neuronal cells and induced neural stem cells (Q27025605) (← links)
- Cellular reprogramming in skin cancer (Q27027468) (← links)
- Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells (Q27310384) (← links)
- Examination of the expanding pathways for the regulation of p21 expression and activity (Q27692024) (← links)
- Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases (Q28073204) (← links)
- In vitro models of cancer stem cells and clinical applications (Q28076101) (← links)
- Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness (Q28077156) (← links)
- Present and future challenges of induced pluripotent stem cells (Q28082747) (← links)
- Reprogramming with Small Molecules instead of Exogenous Transcription Factors (Q28084394) (← links)
- Lost highway(s): barriers to postnatal cortical neurogenesis and implications for brain repair (Q28084984) (← links)
- Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies (Q28085565) (← links)
- Forward engineering neuronal diversity using direct reprogramming (Q28087195) (← links)
- A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype (Q28117127) (← links)
- The oncogene c-Jun impedes somatic cell reprogramming (Q28263863) (← links)
- MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53 (Q28271894) (← links)
- Loss of a single allele for Ku80 leads to progenitor dysfunction and accelerated aging in skeletal muscle (Q28273548) (← links)
- Control of Oxidative Stress and Generation of Induced Pluripotent Stem Cell-like Cells by Jun Dimerization Protein 2 (Q28301456) (← links)
- The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma (Q28307211) (← links)
- ANRIL: molecular mechanisms and implications in human health (Q28394102) (← links)